How VC Firms Use Scaleflow's X-Ray to Win Better Deals

After 200+ tech assessments for investors, we've noticed a clear pattern: the firms that get the best deals are the ones that understand the technology earliest. Not at the end of the process. At the beginning.

Tech DD is still too late in most processes

Most VC and PE firms run tech DD at the formal due diligence stage — after the term sheet, after the valuation is locked. At that point, it's confirmatory. You're not discovering risk to price it in — you're confirming a decision you've already made.

As one of our investor partners put it: 'Tech has a direct impact on valuation. Running it late is a missed opportunity.' The firms that move the assessment earlier — to the initial screening or pre-term sheet phase — gain leverage the others don't have.

What investors actually want to know

After hundreds of conversations with deal teams, investor questions consistently fall into three buckets:

• Flags — is there a red flag that should stop or reprice this deal?
• Context — is that flag actually a problem in THIS specific context?
• Crown jewels — what stands out positively that supports the thesis?

Our reports are structured around exactly these three things. Not a 50-page technical appendix — a clear read that answers: should I invest, what should I watch, and what's the real value here.

Speed is the competitive advantage

Deals move fast. Founders have multiple term sheets. The fund that hesitates loses the deal. Traditional tech DD takes 3-6 weeks and costs €25-50K. By then, the deal is gone or the price is locked.

The X-Ray delivers a full tech read in 1 business day. It's completely hands-off for the target company — read-only access to the codebase, no disruption to the team, no 80-page questionnaire. The deal team gets the picture before they commit.

One investor framed it perfectly: 'If you're willing to pay the price for perfection, you better make sure you actually know what you're paying for. The rest of the market doesn't have that confidence yet.'

From one-off scans to deal flow infrastructure

The most sophisticated firms don't use the X-Ray as a one-off. They build it into their deal process as infrastructure: screen every serious target, benchmark across portfolio companies, track technical health over time.

One VC firm went from running tech DD on 2-3 deals per year to screening 12-18 — because the X-Ray made it fast enough to do on every serious target. That's not more work. That's better filtering.

Patterns we see across 200+ assessments

After doing this at scale, certain patterns emerge that individual investors can't see from their own portfolio alone:

• 72% of companies have key-person dependencies the investor didn't know about
• Cost-to-serve is the #1 concern for growth-stage investors — not code quality
• Tech debt is almost never a deal-breaker on its own. Tech debt + leadership gap = red flag
• The strongest companies share one trait: their technology decisions reflect their commercial strategy

For investors

If you're evaluating deals and want a tech read before the term sheet — or even during initial screening — that's exactly what the X-Ray delivers. 1 business day. Hands-off. Two reports: one for your deal team, one for the company.